Skip to content
Back to catalog

Growth & Performance

CJC-1295 (No DAC) + Ipamorelin

Axiom Source CJC-1295 (No DAC) + Ipamorelin research peptide vial

Choose an option

Select the amount per vial, then choose a package size.

Amount per vial

Package size

Your estimate includes a flat $65 shipping charge and an 8% transaction fee on the product subtotal. No payment is collected here.

Overview

A classic and highly studied GHRH/GHRP combination stack. CJC-1295 without DAC (also called Modified GRF 1-29) is a short-acting GHRH analogue that produces a strong, physiological GH pulse when combined with a GHRP. Ipamorelin is a selective growth hormone secretagogue that stimulates GH release without significantly raising cortisol or prolactin. Together, they act synergistically — CJC-1295 amplifies the size of GH pulses while Ipamorelin increases pulse frequency and selectivity. This stack is one of the most researched and trusted protocols for GH optimization, muscle recovery, fat metabolism, and sleep quality improvement.

Selected variation
CJC-1295 (No DAC) + Ipamorelin
Amount per vial
CJC 5mg+IPA 5mg
Intended use
Laboratory research only
Route of administration
Subcutaneous injection

Research information

This blend combines CJC-1295 (No DAC) and Ipamorelin, two peptides that work together to stimulate the release of growth hormone. CJC-1295 acts as a growth hormone-releasing hormone analog, while Ipamorelin is a selective growth hormone secretagogue. Researchers study this combination to understand its effects on metabolic processes and tissue growth, though evidence remains largely preclinical.

For laboratory research only. Not for human or animal consumption. Catalog information is not medical advice or a claim of therapeutic benefit.

For laboratory research only. Not for human or animal consumption. This catalog provides estimates and quote requests; it does not process purchases.

© 2026 Axiom Source